Source:http://linkedlifedata.com/resource/pubmed/id/21357943
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2011-4-4
|
pubmed:abstractText |
Posaconazole is a triazole with anti-Aspergillus activity. However, little is known about the utility of posaconazole as primary therapy for invasive pulmonary aspergillosis.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1537-6613
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
203
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1324-32
|
pubmed:meshHeading |
pubmed-meshheading:21357943-Animals,
pubmed-meshheading:21357943-Antifungal Agents,
pubmed-meshheading:21357943-Disease Models, Animal,
pubmed-meshheading:21357943-Invasive Pulmonary Aspergillosis,
pubmed-meshheading:21357943-Male,
pubmed-meshheading:21357943-Mice,
pubmed-meshheading:21357943-Models, Theoretical,
pubmed-meshheading:21357943-Triazoles
|
pubmed:year |
2011
|
pubmed:articleTitle |
Pharmacokinetics and pharmacodynamics of posaconazole for invasive pulmonary aspergillosis: clinical implications for antifungal therapy.
|
pubmed:affiliation |
School of Translational Medicine, The University of Manchester, Manchester Academic Health Science Centre, National Institute for Health Research Translational Research Facility in Respiratory Medicine, University Hospital of South Manchester National Health Service, Foundation Trust, Manchester, United Kingdom.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|